Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft Rejection | 45 | 2022 | 4426 | 3.420 |
Why?
|
Transplantation Tolerance | 16 | 2022 | 605 | 3.120 |
Why?
|
Isoantigens | 16 | 2022 | 552 | 2.650 |
Why?
|
Transplantation, Homologous | 46 | 2022 | 4815 | 2.050 |
Why?
|
Skin Transplantation | 19 | 2020 | 1083 | 2.010 |
Why?
|
T-Lymphocytes | 41 | 2022 | 10181 | 1.780 |
Why?
|
Immune Tolerance | 25 | 2022 | 2299 | 1.470 |
Why?
|
Chimerism | 9 | 2022 | 155 | 1.440 |
Why?
|
Exosomes | 3 | 2021 | 423 | 1.410 |
Why?
|
Antigen Presentation | 13 | 2020 | 1254 | 1.180 |
Why?
|
Immunologic Memory | 11 | 2020 | 1354 | 1.170 |
Why?
|
Graft Survival | 20 | 2018 | 3795 | 1.060 |
Why?
|
Histocompatibility Antigens | 9 | 2022 | 467 | 0.970 |
Why?
|
Kidney Transplantation | 14 | 2022 | 4214 | 0.960 |
Why?
|
Bone Marrow Transplantation | 14 | 2015 | 2693 | 0.950 |
Why?
|
Heart Transplantation | 17 | 2018 | 3224 | 0.910 |
Why?
|
Major Histocompatibility Complex | 13 | 2015 | 928 | 0.870 |
Why?
|
Corneal Transplantation | 7 | 2013 | 321 | 0.870 |
Why?
|
Histocompatibility Antigens Class II | 12 | 2010 | 1446 | 0.860 |
Why?
|
Antigen-Presenting Cells | 8 | 2021 | 967 | 0.840 |
Why?
|
Interleukin-2 | 13 | 2016 | 1889 | 0.840 |
Why?
|
Mice, Inbred BALB C | 30 | 2020 | 6216 | 0.780 |
Why?
|
Autoantigens | 11 | 2018 | 877 | 0.730 |
Why?
|
CD8-Positive T-Lymphocytes | 13 | 2020 | 4550 | 0.660 |
Why?
|
Histocompatibility Antigens Class I | 12 | 2009 | 1355 | 0.650 |
Why?
|
Lymphocyte Depletion | 4 | 2015 | 602 | 0.640 |
Why?
|
CD4-Positive T-Lymphocytes | 17 | 2020 | 4353 | 0.620 |
Why?
|
Macaca fascicularis | 13 | 2015 | 900 | 0.620 |
Why?
|
Transplantation Immunology | 3 | 2011 | 532 | 0.590 |
Why?
|
Transplantation Chimera | 6 | 2015 | 595 | 0.570 |
Why?
|
H-2 Antigens | 4 | 2010 | 358 | 0.560 |
Why?
|
Lymphocyte Activation | 19 | 2013 | 5496 | 0.550 |
Why?
|
Isoantibodies | 4 | 2015 | 661 | 0.540 |
Why?
|
Animals | 93 | 2022 | 167960 | 0.510 |
Why?
|
Antigens, CD20 | 1 | 2015 | 201 | 0.480 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2016 | 265 | 0.470 |
Why?
|
Transplantation Conditioning | 10 | 2016 | 1593 | 0.460 |
Why?
|
Dendritic Cells | 5 | 2013 | 2725 | 0.460 |
Why?
|
Peptides | 12 | 2001 | 4354 | 0.440 |
Why?
|
Receptors, Antigen, T-Cell | 7 | 2010 | 2536 | 0.440 |
Why?
|
Self Tolerance | 5 | 2006 | 124 | 0.440 |
Why?
|
Interferon-gamma | 17 | 2016 | 3157 | 0.440 |
Why?
|
T-Lymphocyte Subsets | 9 | 2014 | 1810 | 0.430 |
Why?
|
Lymphoid Tissue | 1 | 2014 | 445 | 0.430 |
Why?
|
Mice | 59 | 2021 | 81209 | 0.430 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 410 | 0.410 |
Why?
|
Free Radical Scavengers | 2 | 2006 | 211 | 0.390 |
Why?
|
Th1 Cells | 9 | 2009 | 1032 | 0.380 |
Why?
|
Th2 Cells | 9 | 2009 | 1047 | 0.370 |
Why?
|
Autoimmunity | 8 | 2009 | 1370 | 0.370 |
Why?
|
Myosins | 3 | 2002 | 405 | 0.370 |
Why?
|
Transplants | 1 | 2013 | 206 | 0.370 |
Why?
|
Tissue Donors | 3 | 2018 | 2314 | 0.350 |
Why?
|
Mice, Inbred C57BL | 26 | 2020 | 22020 | 0.330 |
Why?
|
Immunomodulation | 1 | 2013 | 547 | 0.320 |
Why?
|
B-Lymphocytes | 4 | 2020 | 4742 | 0.320 |
Why?
|
CD40 Ligand | 7 | 2013 | 521 | 0.300 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2000 | 824 | 0.300 |
Why?
|
Mice, Inbred CBA | 5 | 2010 | 436 | 0.290 |
Why?
|
Cardiac Myosins | 3 | 2018 | 127 | 0.290 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2015 | 3075 | 0.280 |
Why?
|
Maternal-Fetal Exchange | 3 | 2020 | 463 | 0.270 |
Why?
|
Organ Transplantation | 1 | 2016 | 1150 | 0.260 |
Why?
|
Antibodies, Monoclonal | 8 | 2015 | 9185 | 0.250 |
Why?
|
Killer Cells, Natural | 2 | 2012 | 2203 | 0.250 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5659 | 0.240 |
Why?
|
Epitopes | 8 | 2002 | 2503 | 0.240 |
Why?
|
Mice, Inbred C3H | 3 | 2015 | 915 | 0.240 |
Why?
|
Bone Marrow Cells | 3 | 2013 | 2414 | 0.230 |
Why?
|
Manganese | 1 | 2006 | 395 | 0.220 |
Why?
|
Adaptation, Physiological | 2 | 2007 | 1296 | 0.220 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2470 | 0.210 |
Why?
|
Diphtheria Toxin | 2 | 2014 | 252 | 0.210 |
Why?
|
Peptide Fragments | 9 | 2003 | 5132 | 0.200 |
Why?
|
HLA Antigens | 2 | 1998 | 1368 | 0.190 |
Why?
|
Adaptive Immunity | 2 | 2020 | 726 | 0.190 |
Why?
|
Luminescent Measurements | 6 | 1991 | 378 | 0.180 |
Why?
|
Sarcoma, Experimental | 1 | 2000 | 117 | 0.180 |
Why?
|
Skin | 1 | 2013 | 4466 | 0.170 |
Why?
|
Amino Acid Sequence | 11 | 2014 | 13451 | 0.170 |
Why?
|
Mice, Transgenic | 5 | 2015 | 9530 | 0.160 |
Why?
|
Immunosuppressive Agents | 6 | 2015 | 4167 | 0.160 |
Why?
|
Molecular Sequence Data | 12 | 2014 | 17624 | 0.160 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2138 | 0.160 |
Why?
|
Swine, Miniature | 3 | 2016 | 959 | 0.150 |
Why?
|
Autoimmune Diseases | 4 | 2010 | 2250 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2006 | 2924 | 0.150 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2014 | 305 | 0.150 |
Why?
|
Ethylenediamines | 1 | 1997 | 57 | 0.140 |
Why?
|
Vimentin | 1 | 2018 | 255 | 0.140 |
Why?
|
Alopecia Areata | 1 | 1999 | 127 | 0.140 |
Why?
|
Interleukin-4 | 3 | 2011 | 1130 | 0.140 |
Why?
|
Models, Immunological | 2 | 2010 | 513 | 0.130 |
Why?
|
Kidney Function Tests | 2 | 2015 | 681 | 0.130 |
Why?
|
Lung Transplantation | 2 | 2015 | 1305 | 0.130 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2013 | 57 | 0.130 |
Why?
|
Biological Factors | 1 | 1995 | 157 | 0.120 |
Why?
|
Antibodies, Neoplasm | 2 | 2006 | 280 | 0.120 |
Why?
|
Interleukin-15 | 2 | 2012 | 183 | 0.120 |
Why?
|
Macrophage Activation | 2 | 1988 | 554 | 0.120 |
Why?
|
Papio | 1 | 2016 | 661 | 0.120 |
Why?
|
Lymphocyte Transfusion | 1 | 2015 | 232 | 0.120 |
Why?
|
Organ Specificity | 2 | 2013 | 1954 | 0.110 |
Why?
|
Myocardium | 3 | 2012 | 4700 | 0.110 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 680 | 0.110 |
Why?
|
Swine | 4 | 2022 | 5899 | 0.110 |
Why?
|
Receptors, Fc | 2 | 1987 | 534 | 0.110 |
Why?
|
Adolescent Psychiatry | 1 | 1995 | 157 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 1997 | 662 | 0.110 |
Why?
|
Postoperative Complications | 2 | 2015 | 15679 | 0.110 |
Why?
|
Mice, Inbred Strains | 6 | 2003 | 1763 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 220 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2020 | 3047 | 0.110 |
Why?
|
Psychophysiologic Disorders | 1 | 1995 | 221 | 0.110 |
Why?
|
Transplantation, Isogeneic | 3 | 2002 | 248 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2009 | 3802 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 4 | 2014 | 3734 | 0.100 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2015 | 739 | 0.100 |
Why?
|
Mice, Inbred A | 4 | 2004 | 246 | 0.100 |
Why?
|
Immunotoxins | 1 | 2012 | 175 | 0.100 |
Why?
|
Immunoconjugates | 2 | 2014 | 949 | 0.100 |
Why?
|
Myocarditis | 1 | 1999 | 766 | 0.100 |
Why?
|
Radiation Chimera | 1 | 2011 | 216 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1997 | 825 | 0.100 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2011 | 57 | 0.090 |
Why?
|
School Health Services | 1 | 1995 | 382 | 0.090 |
Why?
|
Injections, Intraperitoneal | 3 | 2001 | 412 | 0.090 |
Why?
|
Thymus Gland | 3 | 2010 | 1247 | 0.090 |
Why?
|
Maleimides | 1 | 2011 | 113 | 0.090 |
Why?
|
Zymosan | 2 | 1988 | 135 | 0.090 |
Why?
|
Retina | 1 | 2001 | 2635 | 0.090 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2012 | 280 | 0.090 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 983 | 0.080 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2012 | 305 | 0.080 |
Why?
|
Flow Cytometry | 4 | 2014 | 5869 | 0.080 |
Why?
|
Adoptive Transfer | 2 | 2009 | 822 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2014 | 14374 | 0.080 |
Why?
|
Transduction, Genetic | 2 | 2010 | 897 | 0.080 |
Why?
|
beta Catenin | 2 | 2011 | 1043 | 0.080 |
Why?
|
Intracellular Space | 1 | 2010 | 197 | 0.080 |
Why?
|
Cells, Cultured | 6 | 2011 | 18955 | 0.080 |
Why?
|
Proteins | 2 | 2022 | 6029 | 0.080 |
Why?
|
Immunoglobulin G | 5 | 2003 | 4542 | 0.080 |
Why?
|
Chronic Disease | 5 | 2011 | 9288 | 0.080 |
Why?
|
Pulmonary Alveoli | 2 | 1988 | 653 | 0.080 |
Why?
|
Models, Animal | 3 | 2015 | 2117 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 886 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 2379 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2011 | 1342 | 0.070 |
Why?
|
Cytokines | 4 | 2009 | 7344 | 0.070 |
Why?
|
Crosses, Genetic | 3 | 2003 | 751 | 0.070 |
Why?
|
Retroviridae | 1 | 2010 | 850 | 0.070 |
Why?
|
Serine | 1 | 2011 | 831 | 0.070 |
Why?
|
Immunotherapy | 3 | 1999 | 4642 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1792 | 0.070 |
Why?
|
Immunization | 3 | 2011 | 1227 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2180 | 0.070 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 1613 | 0.070 |
Why?
|
Hepatovirus | 2 | 1997 | 45 | 0.070 |
Why?
|
Female | 20 | 2020 | 391246 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1754 | 0.070 |
Why?
|
Catalase | 1 | 2006 | 216 | 0.070 |
Why?
|
Viral Hepatitis Vaccines | 2 | 1997 | 75 | 0.070 |
Why?
|
Male | 20 | 2020 | 359718 | 0.060 |
Why?
|
Hepatitis A | 2 | 1997 | 132 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2015 | 2063 | 0.060 |
Why?
|
Guinea Pigs | 3 | 1997 | 1316 | 0.060 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2005 | 56 | 0.060 |
Why?
|
Hypersensitivity, Delayed | 4 | 2011 | 490 | 0.060 |
Why?
|
Granulocytes | 1 | 1987 | 551 | 0.060 |
Why?
|
Phagocytosis | 1 | 2011 | 1535 | 0.060 |
Why?
|
Granuloma | 1 | 1987 | 327 | 0.060 |
Why?
|
Pregnancy | 3 | 2020 | 29746 | 0.060 |
Why?
|
Antibodies | 2 | 2003 | 2421 | 0.060 |
Why?
|
Catalysis | 1 | 2006 | 775 | 0.060 |
Why?
|
Lung Diseases | 1 | 2015 | 1915 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1547 | 0.060 |
Why?
|
Immunity | 1 | 1990 | 998 | 0.060 |
Why?
|
Humans | 32 | 2020 | 760613 | 0.060 |
Why?
|
Signal Transduction | 5 | 2011 | 23374 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 594 | 0.060 |
Why?
|
Free Radicals | 3 | 1989 | 238 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2014 | 2093 | 0.060 |
Why?
|
Graft vs Host Reaction | 1 | 2003 | 103 | 0.060 |
Why?
|
Lymphocytes | 1 | 2011 | 2611 | 0.050 |
Why?
|
Antigens, Surface | 1 | 1987 | 1608 | 0.050 |
Why?
|
Phosphorylation | 2 | 2011 | 8311 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1829 | 0.050 |
Why?
|
Maternal Behavior | 1 | 2005 | 306 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2006 | 1351 | 0.050 |
Why?
|
Spleen | 3 | 2011 | 2298 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2011 | 11481 | 0.050 |
Why?
|
Macrophages | 2 | 1988 | 5745 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2119 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3390 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2001 | 516 | 0.050 |
Why?
|
Cornea | 3 | 2004 | 1326 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2002 | 268 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6538 | 0.050 |
Why?
|
Freund's Adjuvant | 1 | 2001 | 149 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4356 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2007 | 4286 | 0.040 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 433 | 0.040 |
Why?
|
Monocytes | 3 | 1994 | 2575 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2010 | 3380 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 630 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2003 | 835 | 0.040 |
Why?
|
Mice, Inbred DBA | 3 | 2011 | 622 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 1088 | 0.040 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 111 | 0.040 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 482 | 0.040 |
Why?
|
Blood Cells | 1 | 2002 | 305 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3725 | 0.040 |
Why?
|
Minor Histocompatibility Loci | 1 | 1999 | 16 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1765 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 3026 | 0.040 |
Why?
|
Primates | 2 | 2015 | 523 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2192 | 0.040 |
Why?
|
Cancer Vaccines | 1 | 2006 | 1046 | 0.040 |
Why?
|
Histocompatibility Testing | 2 | 2015 | 717 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6130 | 0.040 |
Why?
|
Kinetics | 2 | 1999 | 6377 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 1998 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2006 | 1881 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 1999 | 402 | 0.040 |
Why?
|
Bone Marrow | 1 | 1987 | 2914 | 0.040 |
Why?
|
Mutation | 2 | 2006 | 29957 | 0.030 |
Why?
|
DNA, Complementary | 1 | 2000 | 1991 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2014 | 0.030 |
Why?
|
Membrane Glycoproteins | 3 | 2004 | 3709 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 1988 | 899 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2001 | 3486 | 0.030 |
Why?
|
Psychiatric Nursing | 1 | 1995 | 15 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2001 | 1039 | 0.030 |
Why?
|
Lymphokines | 1 | 1998 | 927 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9468 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4169 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5640 | 0.030 |
Why?
|
Horses | 1 | 2015 | 298 | 0.030 |
Why?
|
Cross Reactions | 1 | 1996 | 818 | 0.030 |
Why?
|
Receptors, IgG | 2 | 1987 | 558 | 0.030 |
Why?
|
Cell Transplantation | 1 | 1995 | 472 | 0.030 |
Why?
|
Ligands | 1 | 2001 | 3276 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 226 | 0.030 |
Why?
|
Professional Misconduct | 1 | 1994 | 73 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 1991 | 1414 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1664 | 0.030 |
Why?
|
Scientific Misconduct | 1 | 1994 | 74 | 0.030 |
Why?
|
Protein Binding | 2 | 2014 | 9335 | 0.030 |
Why?
|
Genes, MHC Class II | 1 | 1994 | 451 | 0.030 |
Why?
|
Inflammation | 2 | 2015 | 10755 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 778 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1991 | 818 | 0.020 |
Why?
|
Blood | 1 | 1994 | 586 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 74333 | 0.020 |
Why?
|
Blood Group Incompatibility | 1 | 2011 | 135 | 0.020 |
Why?
|
Superoxides | 1 | 1991 | 387 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2120 | 0.020 |
Why?
|
Cell Division | 2 | 2002 | 4463 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 1989 | 101 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 4716 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13627 | 0.020 |
Why?
|
Rats | 2 | 2006 | 23709 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 413 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1991 | 545 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10826 | 0.020 |
Why?
|
Rosette Formation | 1 | 1987 | 152 | 0.020 |
Why?
|
Mice, SCID | 2 | 2004 | 2627 | 0.020 |
Why?
|
Biopsy | 2 | 2012 | 6771 | 0.020 |
Why?
|
Lectins | 1 | 1989 | 484 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4626 | 0.020 |
Why?
|
Cell Line | 4 | 2014 | 15620 | 0.020 |
Why?
|
Acrylic Resins | 1 | 1987 | 135 | 0.020 |
Why?
|
Immunoglobulin Isotypes | 1 | 1987 | 158 | 0.020 |
Why?
|
Pilot Projects | 2 | 2015 | 8556 | 0.020 |
Why?
|
HIV | 1 | 1994 | 1579 | 0.020 |
Why?
|
Gamma Rays | 1 | 1988 | 317 | 0.020 |
Why?
|
Time Factors | 3 | 2004 | 40139 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7268 | 0.020 |
Why?
|
Base Sequence | 2 | 2014 | 12444 | 0.020 |
Why?
|
Gammaproteobacteria | 1 | 2006 | 28 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6853 | 0.020 |
Why?
|
Isotopes | 1 | 2006 | 125 | 0.020 |
Why?
|
Vaccines, Inactivated | 2 | 1997 | 180 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1997 | 3142 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2006 | 311 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2006 | 152 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2197 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2006 | 297 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6498 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1345 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1652 | 0.010 |
Why?
|
Kidney | 2 | 2011 | 7064 | 0.010 |
Why?
|
Clonal Anergy | 1 | 2004 | 171 | 0.010 |
Why?
|
Antigens, CD | 2 | 2004 | 4000 | 0.010 |
Why?
|
Busulfan | 1 | 2003 | 258 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2003 | 1385 | 0.010 |
Why?
|
Immune Sera | 1 | 2001 | 613 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3442 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 2001 | 242 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1987 | 1843 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2000 | 93 | 0.010 |
Why?
|
Point Mutation | 1 | 2006 | 1594 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5797 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 1174 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2000 | 193 | 0.010 |
Why?
|
Tacrolimus | 1 | 2003 | 733 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1006 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12957 | 0.010 |
Why?
|
Adipocytes | 1 | 2006 | 1179 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10442 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 911 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2003 | 2671 | 0.010 |
Why?
|
Antibody Formation | 1 | 2002 | 1400 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1671 | 0.010 |
Why?
|
Oxygen | 1 | 1989 | 4193 | 0.010 |
Why?
|
Hepatitis A Vaccines | 1 | 1997 | 26 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 2057 | 0.010 |
Why?
|
Neoplasms | 1 | 2006 | 22075 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 8055 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2394 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9994 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 1859 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2723 | 0.010 |
Why?
|
Immunogenetics | 1 | 1995 | 66 | 0.010 |
Why?
|
Consumer Product Safety | 1 | 1995 | 123 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4925 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16548 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2006 | 11902 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2006 | 3539 | 0.010 |
Why?
|
France | 1 | 1994 | 511 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18137 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2640 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2003 | 3112 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11070 | 0.010 |
Why?
|
DNA | 1 | 2006 | 7233 | 0.010 |
Why?
|
Ionomycin | 1 | 1991 | 109 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11152 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 12762 | 0.010 |
Why?
|
Trans-Activators | 1 | 2000 | 2860 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1249 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1994 | 1126 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1995 | 1722 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39262 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1991 | 356 | 0.010 |
Why?
|
Adolescent | 2 | 1995 | 87809 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1994 | 1602 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14661 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1991 | 1529 | 0.000 |
Why?
|
Disulfides | 1 | 1988 | 466 | 0.000 |
Why?
|
Molecular Weight | 1 | 1988 | 2186 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1744 | 0.000 |
Why?
|
Protein Processing, Post-Translational | 1 | 1993 | 1974 | 0.000 |
Why?
|
Binding Sites | 1 | 1993 | 6048 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20080 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9591 | 0.000 |
Why?
|
Staphylococcus aureus | 1 | 1991 | 1462 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1994 | 5782 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29661 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2002 | 64981 | 0.000 |
Why?
|
Middle Aged | 1 | 1995 | 220359 | 0.000 |
Why?
|
Adult | 1 | 1995 | 220007 | 0.000 |
Why?
|